These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 4432044)

  • 1. Interaction between secretin and cholecystokinin on inhibition of gastric secretion in man.
    Henriksen FW; Jörgensen SP; Möller S
    Scand J Gastroenterol; 1974 Nov; 9(8):735-40. PubMed ID: 4432044
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of pentagastrin, exogenous secretin, and cholecystokinin (CCK) on the intrinsic factor (IF) secretion in man.
    Vatn MH
    Scand J Gastroenterol Suppl; 1974; 29():53-6. PubMed ID: 4610721
    [No Abstract]   [Full Text] [Related]  

  • 3. Gastric stimulation by intravenous injection of cholecystokinin and secretin in fistula chickens.
    Burhol PG
    Scand J Gastroenterol; 1974; 9(1):49-53. PubMed ID: 4453805
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of graded doses of pentagastrin and secretin on the intrinsic factor (IF) secretion in man.
    Vatn MH; Petersen H; Myren J
    Scand J Gastroenterol; 1974; 9(7):691-5. PubMed ID: 4610712
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of exogenous secretin and cholecystokinin (CCK) on pentagastrin-stimulated intrinsic factor (IF) secretion in man.
    Vatn MH; Berstad A; Myren J
    Scand J Gastroenterol; 1974; 9(3):313-18. PubMed ID: 4605241
    [No Abstract]   [Full Text] [Related]  

  • 6. Secretin snuff: evaluation of the action on pentagastrin-stimulated gastric acid secretion and on pancreatic bicarbonate production.
    Halter F; Witzel L; Kohler B; Hadorn B
    Scand J Gastroenterol; 1975; 10(1):81-5. PubMed ID: 1168364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cholecystokinin, secretin, 2-deoxy-D-glucose and insulin on pentagastrin-stimulated gastric secretion in fistula chickens.
    Burhol PG
    Scand J Gastroenterol; 1974; 9(1):55-8. PubMed ID: 4616329
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of secretin and cholecystokinin on gastric emptying and gastric secretion in man.
    Chey WY; Hitanant S; Hendricks J; Lorber SH
    Gastroenterology; 1970 Jun; 58(6):820-7. PubMed ID: 5423893
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the external pancreatic secretion.
    Henriksen FW
    Scand J Gastroenterol Suppl; 1974; 26():1-94. PubMed ID: 4528745
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of inhibition of acid secretion in anesthetized rats.
    Schmidt HA; Goebell H; Johannson F
    Acta Hepatogastroenterol (Stuttg); 1973; 20(1):51-7. PubMed ID: 4757778
    [No Abstract]   [Full Text] [Related]  

  • 11. Secretin-induced inhibition of acid secretion before and after vagal denervation of canine gastric pouches.
    Sjödin L; Miura S
    Scand J Gastroenterol; 1974; 9(2):185-90. PubMed ID: 4594373
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of gastrin I, secretin and cholecystokinin-pancreozymin on the electrical activity, motor activity, and acid output of the stomach in man.
    Kwong NK; Brown BH; Whittaker GE; Duthie HL
    Scand J Gastroenterol; 1972; 7(2):161-70. PubMed ID: 5021062
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of pentagastrin on cholecystokinin and secretin choleresis in the dog.
    Kaminski DL; Rose RC; Nahrwold DL
    J Surg Res; 1974 Jul; 17(1):26-9. PubMed ID: 4841861
    [No Abstract]   [Full Text] [Related]  

  • 14. Acid and pepsin secretion in duodenal ulcer patients in response to graded doses of pentagastrin or pentagastrin and carbacholine before and after proximal gastric vagotomy.
    Roland M; Berstad A; Liavåg I
    Scand J Gastroenterol; 1974; 9(6):511-8. PubMed ID: 4607374
    [No Abstract]   [Full Text] [Related]  

  • 15. Gastric response to secretin and pancreoxymin in man.
    Wormsley KG
    Scand J Gastroenterol; 1968; 3(6):632-6. PubMed ID: 4893733
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of gastric secretion by exogenous secretin and cholecystokinin in normals and duodenal ulcer patients.
    Jörgensen SP; Henriksen FW
    Scand J Gastroenterol Suppl; 1976; 37():39-42. PubMed ID: 1064138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pancreatic exocrine secretion in duodenal ulcer patients before and after selective proximal vagotomy of the stomach.
    Berstad A; Roland M; Petersen H; Liaväg I
    Scand J Gastroenterol; 1974; 9(5):431-6. PubMed ID: 4854985
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose of intravenous pentagastrin for maximal acid secretion.
    Desai HG; Zaveri MP; Dalvei HG; Antia FP
    Indian J Med Res; 1972 Aug; 60(8):1164-9. PubMed ID: 4661466
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitory effects of a purified enterogasterone, secretin, and cholecystokinin on histamine-stimulated gastric acid secretion.
    Lucien HW; Itoh Z; Schally AV
    Gastroenterology; 1970 Nov; 59(5):707-11. PubMed ID: 5475129
    [No Abstract]   [Full Text] [Related]  

  • 20. Secretin and cholecystokin-pancreozymin in combination in the inhibition of gastric acid secretion.
    Bedi BS; Debas HT; Wasunna AE; Buxton BF; Gillespie IE
    Gut; 1971 Dec; 12(12):968-72. PubMed ID: 5157135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.